Key result
NAFLD independently predicted increased carotid intima-media thickness (OR 8.4; 95% CI 2.49-29.4; P=0.001) and was associated with higher plaque prevalence (50% vs 25%) compared to controls.
Why the study?
Is nonalcoholic fatty liver disease associated with increased carotid atherosclerosis compared to matched controls?
Case-Control (n=80)
Is nonalcoholic fatty liver disease associated with increased carotid atherosclerosis compared to matched controls?
Odds Ratio: 8.4 (95% CI 2.49–29.4)
p-value: p=0.001
Nonalcoholic fatty liver disease is independently associated with increased carotid intima-media thickness and plaque prevalence, suggesting it is a marker of elevated cardiovascular risk.
NAFLD may mark elevated subclinical carotid atherosclerosis risk; leaves open causal inference and need for prospective outcome trials.
OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) frequently coexists with obesity, diabetes, and dyslipidemia. We examined whether NAFLD was associated with atherosclerosis, as measured by ultrasound in the carotid arteries. METHODS AND RESULTS: Carotid atherosclerosis and cardiovascular risk factors were assessed in 40 patients with an ultrasound diagnosis of primary NAFLD and 40 matched population controls. The metabolic syndrome and all its individual traits, including elevated C-reactive protein, were significantly (P<0.005) more frequent in NAFLD patients than in control subjects. Patients with NAFLD showed more carotid atherosclerosis than controls, with mean intima-media thickness (IMT) of 0.70+/-0.20 mm and 0.54+/-0.13 mm (P<0.0001) and plaque prevalence of 50% and 25% (P=0.021), respectively. By multivariate analysis, older age (odds ratio [OR], 2.5 per 10 years; 95% CI, 1.4 to 4.4; P=0.002), the presence of NAFLD (OR, 8.4; 95% CI, 2.49 to 29.4; P=0.001), and elevated serum ferritin (OR, 3.1; 95% CI, 1.2 to 7.9; P=0.016) were independent predictors of an increased IMT. CONCLUSIONS: Patients with NAFLD show a cluster of risk factors of the metabolic syndrome and advanced carotid atherosclerosis. NAFLD appears to be a feature of the metabolic syndrome, and its detection on abdominal ultrasound should alert to the existence of an increased cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Brea et al. (2005) conducted a case-control in Nonalcoholic fatty liver disease (NAFLD) (n=80). Nonalcoholic fatty liver disease (NAFLD) vs. Matched population controls was evaluated on Increased intima-media thickness (IMT) (OR 8.4, 95% CI 2.49 to 29.4, p=0.001). NAFLD independently predicted increased carotid intima-media thickness (OR 8.4; 95% CI 2.49-29.4; P=0.001) and was associated with higher plaque prevalence (50% vs 25%) compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: